Targeted Oncology Biologics Market Valuation to Reach $162.0 Bn by 2036
Rockville, MD., September 26, 2026 — The Targeted Oncology Biologics Market is projected to grow from USD 71.01 billion in 2026 to USD 162.04 billion by 2036, advancing at a 8.6% CAGR during the forecast period, according to Fact.MR. The market is expected to generate an absolute dollar opportunity of USD 91.03 billion between 2026 and 2036. The expansion is closely linked to precision...
0 Commentarios 0 Acciones 5 Views 0 Vista previa